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Alterations in the expression and activity of the transcriptional coactivator peroxisome
proliferator-activated receptor γ coactivator-1α (ppargc1a or PGC-1α) have been reported in
multiple movement disorders, yet it is unclear how a lack of PGC-1α impacts transcription
and function of the cerebellum, a region with high PGC-1α expression. We show here
that mice lacking PGC-1α exhibit ataxia in addition to the previously described deficits in
motor coordination. Using q-RT-PCR in cerebellar homogenates from PGC-1α−/− mice,
we measured expression of 37 microarray-identified transcripts upregulated by PGC-1α in
SH-SY5Y neuroblastoma cells with neuroanatomical overlap with PGC-1α or parvalbumin
(PV), a calcium buffer highly expressed by Purkinje cells. We found significant reductions
in transcripts with synaptic (complexin1, Cplx1; Pacsin2), structural (neurofilament heavy
chain, Nefh), and metabolic (isocitrate dehydrogenase 3a, Idh3a; neutral cholesterol ester
hydrolase 1, Nceh1; pyruvate dehydrogenase alpha 1, Pdha1; phytanoyl-CoA hydroxylase,
Phyh; ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1, Uqcrfs1)
functions. Using conditional deletion of PGC-1α in PV-positive neurons, we determined
that 50% of PGC-1α expression and a reduction in a subset of these transcripts could
be explained by its concentration in PV-positive neuronal populations in the cerbellum. To
determine whether there were functional consequences associated with these changes,
we conducted stereological counts and spike rate analysis in Purkinje cells, a cell type rich
in PV, from PGC-1α−/− mice. We observed a significant loss of Purkinje cells by 6 weeks
of age, and the remaining Purkinje cells exhibited a 50% reduction in spike rate. Together,
these data highlight the complexity of PGC-1α’s actions in the central nervous system and
suggest that dysfunction in multiple cell types contribute to motor deficits in the context
of PGC-1α deficiency.
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INTRODUCTION
Since the identification of peroxisome proliferator activated
receptor γ coactivator-1α (PGC-1α) as amaster regulator ofmito-
chondrial biogenesis in brown adipose tissue (Puigserver et al.,
1998), a number of studies have demonstrated an association
between PGC-1α dysfunction and neurological disorders, includ-
ing Huntington Disease (Cui et al., 2006; Weydt et al., 2006;
Chaturvedi et al., 2010; Hathorn et al., 2011; Johri et al., 2012;
Puddifoot et al., 2012; Soyal et al., 2012), Parkinson Disease (St-
Pierre et al., 2006; Zheng et al., 2010; Clark et al., 2011; Shin
et al., 2011; Thomas et al., 2012), and Alzheimer Disease (Qin
et al., 2009; Sheng et al., 2012; Pedros et al., 2014). Germline
(Lin et al., 2004; Leone et al., 2005; Lucas et al., 2012) and
nervous system-specific (Lucas et al., 2012) deletion of PGC-1α
causes pronounced neurodegeneration in brain regions involved
in motor control and deficits in motor coordination, and PGC-
1α overexpression can promote neuronal survival and function in
some mouse models (Cui et al., 2006; Mudo et al., 2012; Tsunemi
et al., 2012). However, little is known about the physiological
impact of PGC-1α dysfunction on specific cell types and circuits
in the brain.
PGC-1α can interact with a number of transcription factors
and coactivators to drive expression of metabolic transcriptional
programs in peripheral tissues (Lin, 2009). Throughout the brain,
PGC-1α protein is highly concentrated in neurons expressing the
enzyme glutamic acid decarboxylase 67 (GAD67; Cowell et al.,
2007). We recently determined that in GAD67-positive interneu-
rons of the cortex, PGC-1α is involved in regulating the calcium
buffer parvalbumin (PV), the synaptic proteins synaptogamin 2
(Syt2) and complexin 1 (Cplx1), and the structural protein neu-
rofilament heavy chain (Nefh; Lucas et al., 2010, 2014). These data
indicate that PGC-1α can drive genes besides those involved in
metabolic regulation and that PGC-1α’s role in neurons may be
more complex than previously appreciated.
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Considering the high concentration of PGC-1α in the cerebel-
lum and the role of the cerebellum in motor coordination, we
hypothesized that mice lacking PGC-1α would show transcrip-
tional deficits and evidence of cerebellar dysfunction. Here we
report that PGC-1α−/− mice exhibit ataxia and reductions in
genes involved in metabolism, synaptic function, and structural
support. Alterations in protein expression are restricted to specific
neuronal populations within the cerebellum, especially Purkinje
cells, and Purkinje cell number and firing rate are decreased in
PGC-1α−/− animals. These experiments suggest that PGC-1α is
required for proper gene expression in the cerebellum and that
cerebellar deficits contribute to motor abnormalities associated
with PGC-1α deficiency.
METHODS
ANIMALS
All experimental protocols were approved by the Institutional
Animal Care and Use Committee of the University of Alabama
at Birmingham. PGC-1α−/− mice (Lin et al., 2004) were used for
experiments, and PGC-1α+/+, +/−, and −/− mice were obtained
from offspring of PGC-1α+/− breeding pairs. Conditional dele-
tion of PGC-1α was produced by crossing mice with LoxP sites
flanking the exon 3–5 region of the PGC-1α gene (Lin et al.,
2004; gift of Bruce Spiegelman, Harvard University, Cambridge,
USA) with mice expressing Cre recombinase driven by the PV
promoter (Hippenmeyer et al., 2005; #008069 from the Jackson
Laboratory, Bar Harbor, ME, USA). For conditional knockout
experiments, littermates expressing Cre recombinase without
loxP sites were used as controls. To determine specificity of the
Cre-mediated recombination pattern, PV-Cre mice were cross-
bred to mutant tomato/mutant green reporter mice (Muzumdar
et al., 2007; #007676 from Jackson Laboratory). All mice were
maintained on a C57BL6/J genetic background and housed 2–5
in a cage at 26 ± 2◦C room temperature with food and water
ad libitum. With the exception of behavioral analysis, experiments
were conducted on male and female mice, and no significant
differences were found between male and female mice in any
measure.
CATWALK GAIT ANALYSIS
Gait analysis was performed on 6-month-old male PGC-1α−/−
mice with the CatWalk system (Noldus Information Technology,
Leesburg, VA) as previously described (Hamers et al., 2006).
Briefly, mice traversed a glass walkway (109 × 15 × 0.6 cm) with
dark plastic walls spaced 15 cm apart in a dark room. Light from
an encased fluorescent bulb was internally reflected within the
glass walkway and scattered when the plantar surface of the paw
contacted the walkway floor, thereby producing paw prints. Paw
prints were recorded by a high-speed CCD camera mounted
below the walkway at 50 half-frames/s and were stored on a com-
puter by the associated CatWalk 7.1 acquisition software. Trials
in which the animal stopped or changed direction were excluded
from subsequent analysis, and three uninterrupted trials were
analyzed and averaged to obtain the final gait analysis values.
Paw print designations were assigned and data analyzed using the
CatWalk analysis software (v 7.1) by an experimenter who was
blinded to the genotype of the animals. Mice were tested at 6
months of age because PGC-1α−/− animals weighed significantly
less than PGC-1α+/+ animals at earlier time points (data not
shown), which could bias Catwalk detection and subsequent
analyses of paw prints.
GENE EXPRESSION ANALYSES
Mice, aged 1 month for germline and 6 months for conditional
PGC-1α deletion, were anesthetized with isoflurane before sacri-
fice by decapitation. Cerebella were collected in centrifuge tubes,
flash frozen on dry ice, and stored at −80◦C. Before process-
ing, samples were incubated in RNAlater®-ICE (Ambion, Austin,
TX, USA) according to manufacturer’s instructions. Tissue was
homogenized with Tissue-Tearor (Biospec, Bartlesville, OK, USA)
in Trizol reagent, and RNA was isolated by the Trizol/choloform-
isopropanol method following the manufacturer’s instructions
(Invitrogen, Carlsbad, CA, USA). RNA concentrations and purity
were quantified using a Thermo Scientific NanoDrop2000 (Fisher
Scientific, Pittsburg, PA, USA). Equivalent amounts of RNA
(1μg) were treated with DNase I (Promega, Madison, WI, USA)
at 37◦C for 30min, andDNase was inactivated at 65◦C for 15min.
RNA was reverse-transcribed using the High-Capacity cDNA
Archive Kit (Applied Biosystems, Carlsbad, CA, USA). Taqman
qPCR was performed with JumpStart Taq Readymix (Sigma,
St. Louis, MO, USA) and the following mouse-specific Applied
Biosystems primers listed in Supplementary Table 1.
Reaction protocols consisted of an initial ramp time (2min,
50◦C; 10min, 95◦C) and 40 subsequent cycles (15 s, 95◦C; 1min,
60◦C). Relative concentrations of the genes of interest were calcu-
lated in comparison to a standard curve calculated from dilutions
of cDNA (1:5, 1:10, 1:20) from a pooled sample of wildtype
littermate controls. Values were normalized to β-actin (ABI#
Mm00607939_s1) or 18S rRNA (ABI# Hs99999901_s1) for val-
ues for the same sample and then expressed as ratio to control
samples ± SEM.
WESTERN BLOT ANALYSIS
Primary antibodies included rabbit anti-Cplx1,2 (Synaptic
Systems, Goettingen, Germany), chicken anti-Nefh (Abcam,
Cambridge, MA, USA), rabbit anti-pacsin2 (Sigma), and mouse
anti-β-actin (Chemicon, Billerica, MA, USA). One-month-old
PGC-1α+/+ and −/− mice were anesthetized with isoflurane
before sacrifice by decapitation. Cerebella were collected in cen-
trifuge tubes, flash frozen on dry ice, and stored at −80◦C.
Cerebella were homogenized in RIPA buffer (150mM NaCl,
50mM Tris, 1% Triton X-100, 1% sodium dodecyl sulfate, 0.5%
deoxycholic acid; pH 8.0) containing a protease inhibitor tablet.
Total protein concentration was determined with a bicinchoni-
cic acid protein assay kit (Thermo Scientific, Waltham, MA,
USA), and absorbance was measured at 540 nm. Protein was
denatured in sample buffer (62.5mM Tris-HCl, 20% glycerol,
2% sodium dodecyl sulfate, 5% β-mercaptoethanol; pH 6.8) at
95◦C. Equivalent amounts of protein were loaded into precast
polyacrylamide NuPage gels (Invitrogen). One interblot control
sample was loaded onto every gel to permit comparison among
gels. Protein was transferred onto nitrocellulose membranes.
Membranes were blocked with 5% milk in tris buffered saline
(TBS; pH 7.6) with 1% Tween (TBS-T) and probed with primary
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antibodies in 5% IgG-free bovine serum albumin (BSA; Jackson
ImmunoResearch, West Grove, PA, USA) TBS-T overnight at
4◦C and peroxidase-conjugated secondary antibodies (Jackson
ImmunoResearch) in 5% milk TBS-T for 1 h at room tempera-
ture. Membranes were incubated in chemiluminescent substrate
(Thermo Scientific) and exposed to film. The optical density of
bands was calculated after background subtraction using UN-
SCAN-IT gel analysis software (Silk Scientific Inc., Orem, UT,
USA). All bands were normalized to the interblot control band,
then to actin, and expressed as optical density mean ± SEM.
IMMUNOFLUORESCENCE
Animals were anesthetized with isoflurane and perfused intrac-
ardially with phosphate-buffered saline (PBS, pH 7.4) and 4%
paraformaldehyde in PBS. Brains were removed, postfixed in 4%
paraformaldehyde for 24–72 h, cryoprotected in graded sucrose
(5–20%), embedded in a mixture of 20% sucrose and Tissue-Tek
O.C.T. Compound (Sakura Finetek, Torrance, CA), and frozen
at −80◦C. Tissue blocks were sectioned at 20μm, mounted
onto charged slides (Fisher, Hampton, NH), and allowed to dry
overnight before freezing at −80◦C.
The same primary antibodies were used for immunofluores-
cence as Western blotting (see above) with the addition of mouse
anti-GAD67 (Chemicon), mouse anti-PV (Sigma), and rabbit
anti-PV (Swant, Marly, Switzerland). Slides were thawed, washed
in PBS, and blocked with 10% serum from the host of the sec-
ondary antibody in PBS for 1 h. Sections were then incubated
in the primary antibody overnight with 3% BSA and 5% serum
from the host of the secondary antibody in PBS with Triton-
X100 (PBS-T; Sigma) at 4◦C. Slides were washed in PBS-T and
PBS and incubated 2 h at room temperature with the corre-
sponding fluorescence-conjugated secondary antibody (Jackson
ImmunoResearch) with 5% serum for the host of the secondary
antibody in PBS-T. For colabeling with GAD67, a mouse-on-
mouse kit (Vector Laboratories, Burlingame, CA) was used fol-
lowing the manufacturer’s instructions to reduce background
staining. Sections were coverslipped with Prolong Antifade Gold
(Invitrogen) and stored at 4◦C. All images were captured with a
Leica confocal microscope (Buffalo Grove, IL, USA). All confo-
cal settings, including laser intensity, gain, offset, and zoom, were
held constant across all groups for a given protein. Images were
imported into Adobe Photoshop CS3 (Adobe, San Jose, CA) for
adjustments to contrast and brightness.
STEREOLOGY
Animals were transcardially perfused, and brains were processed
as described above for immunofluorescence. Brains were sec-
tioned 30μm thick in the sagittal plane and stored at −80◦C
until use. Hematoxylin and Eosin (H&E; Sigma) staining was
conducted according to the manufacturer’s instructions on serial
cerebellum sections to visualize Purkinje cells. Stereological anal-
yses were performed with a computerized stereology worksta-
tion, consisting of a modified Olympus BX51 light microscope
(Center Valley, PA, USA) equipped with 4×–100× Plan Apo
objectives, a motorized specimen stage (Ludl Electronic Products
Ltd., Hawthorne, NY, USA), CCD color video camera (CX9000,
Microfire Optronics, Goleta, CA, USA) and StereoInvestigator
10 software (MBF Biosciences, Williston, VT, USA). The optical
fractionator principle (West et al., 1991) was used for estima-
tion of Purkinje cells in the cerebellum. Systematic random
sampling in every 20th section was performed in a total of
11 sections per animal. All cells whose nucleus top came into
focus within the unbiased counting spaces throughout the delin-
eated regions were counted. The systemic random sampling grid
layout was 253 × 188μm with 100 desired sites per animal.
A 60 × 60μm square dissector frame was used to sample the
sections.
LOOSE PATCH RECORDINGS
Loose patch recordings of Purkinje cells were conducted as in
Dougherty et al. (2012). Mice (P42 ± 5 days) were anesthetized
with isoflourane and then killed by decapitation. Brains were
places in ice-cold artificial cerebral spinal fluid (ACSF) contain-
ing the following (in mM): 125 NaCl, 2.5 KCl, 2 CaCl2, 1 MgCl2,
25 NaHCO3 1.25 Na2HPO4and 25 D-glucose with a pH of 7.4
and osmolality of 295 ± 5 mOsm. ACSF was bubbled with
95%O2/5%CO2. Sagittal cerebellar slices (300μm thick) were cut
using a Vibratome (7000 smz, Campden Instruments, Sarasota,
FL, USA). The slices were allowed to rest for 60min at room
temperature (22–23◦C), and all subsequent procedures were per-
formed at room temperature. Slices were superfused continuously
with oxygenated recording ACSF at room temperature. Slices
were viewed with an upright microscope (Zeiss Axio Examiner
A1, Thornwood, NY, USA) using infrared-differential interfer-
ence contrast optics. Loose patch recordings were acquired from
visually identified Purkinje cells using Axio Vision 4.8 software
(Zeiss). Cellular activity was recorded using internal solution con-
taining the following (in mM): 140 K-gluconate, 1 EGTA, 10
HEPES and 5 KCL, pH 7.3. Pipette tip resistance was 2–5M. The
extracellular recording pipettes containing the internal solution
were placed under visual control directly adjacent to the soma of
the cell of interest. Positive pressure was applied throughout this
process followed by a brief release of pressure to form a seal aver-
aging approximately 45 M. Cell-attached, loose patch-clamp
recordings were obtained using an Axon CNS Molecular Devices
amplifier (Multiclamp 700B, Molecular Devices, Sunnydale, CA,
USA), filtered at 10 kHz and digitized at 20 kHz (Digidata 1440A,
Molecular Devices). A 3min gap-free protocol on Clampex
10.2 software (Molecular Devices) was used for data collection.
Detection and analysis of event frequency and inter-event interval
were performed semi-automatically using the program Clampfit
10.2. The detection threshold was set for analysis based on the
event amplitude from a given cell.
STATISTICAL ANALYSES
All statistical analyses were conducted with SPSS software (IBM,
Armonk, NY, USA). For initial gene expression studies, One-
way ANOVA comparing +/+, +/−, and −/− mice followed by
Fisher’s LSD was implemented. After determination of putative
gene targets in the cerebellum, confirmation of protein expres-
sion in −/− mice and gene expression in conditional knockouts
was analyzed with one-tailed t-tests with the a priori hypothesis
that gene and protein expression would decrease in mice lack-
ing PGC-1α. All other differences between PGC-1α+/+ and −/−
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mice were detected by two-tailed t-tests. All data are presented as
mean ± SEM.
RESULTS
MICE LACKING PGC-1α EXHIBIT ATAXIA
PGC-1α−/− mice were previously described to have severe
motor abnormalities indicative of neurological dysfunction, such
as impaired rotarod performance, decreased rearing behavior,
hindlimb clasping, and tremor (Lucas et al., 2012). Given the high
expression of PGC-1α in the cerebellum compared to other brain
regions (Cowell et al., 2007), we hypothesized that motor impair-
ment in PGC-1α−/− animals would include ataxia and conducted
CatWalk gait analyses on male PGC-1α+/+ and −/− littermates
at 6 months of age. CatWalk gait analyses have been validated as
indicators ofmotor abnormalities in rodents, and several CatWalk
variables indicating paw print dimensions and the time and dis-
tance relationships between footfalls are affected in rodentmodels
of neurological diseases in which PGC-1α has been implicated,
such as Huntington (Vandeputte et al., 2010) and Parkinson
(Vlamings et al., 2007; Chuang et al., 2010) Diseases. We assessed
paw print area, which indicates the average area of each paw print
over a 4 step cycle sequence, and found that PGC-1α−/− mice
exhibited reduced hindpaw area compared to PGC-1α+/+ mice
[t(18) = 2.53, p = 0.02; Figure 1A]. We also evaluated the stand
index, which is ratio of all maximum paw contact values (stance)
over the stance duration (seconds), normalized for camera acqui-
sition rate. PGC-1α−/− animals exhibited an increased hindpaw
stand index [t(18) = 2.53, p = 0.02], indicating greater duration
stance than PGC-1α+/+ mice (Figure 1B). Similarly, the aver-
age speed in the swing phase of the step cycle, or swing speed,
was found to be decreased for the forepaws [t(18) = 3.74, p =
0.002] and hindpaws [t(18) = 3.25, p = 0.004] of PGC-1α−/−
mice (Figure 1C). Missteps indicate an instance in the step cycle
wherein a paw was not placed in a step sequence, and PGC-
1α−/− mice exhibited an increased number of missteps compared
to their wildtype littermates [t(15) = 2.58, p = 0.02; Figure 1D].
Figure 1E is comprised of representative traces showing color-
coded, digitized paw prints and corresponding step cycles for
PGC-1α−/− and PGC-1α+/+ mice. Taken together, these data
demonstrate that the motor phenotype of PGC-1α−/− mice
includes ataxia characterized by altered gait kinematics, including
increased stance duration, increased paw placement, and stepping
mistakes.
NOVEL CEREBELLAR PGC-1α-DEPENDENT GENES
Little is known about the downstream gene targets of PGC-1α
in the cerebellum, despite the high concentration of PGC-1α in
this brain region (Cowell et al., 2007). To identify novel PGC-1α-
dependent transcripts in the cerebellum, we used an approach our
laboratory recently used to identify PGC-1α-dependent genes in
the cortex in which we mined microarray data comparing human
SH-SY5Y neuroblastoma cells overexpressing PGC-1α and GFP
in tandem to cells expressing GFP alone (Lucas et al., 2014;
GEO NCBI database registration in progress). Transcripts were
selected to measure in cerebellar homogenates based on three
criteria: (1) all of the top 10 transcripts significantly upregu-
lated by PGC-1α overexpression with a murine homolog, (2)
transcripts listed on the whole-brain PGC-1α Neuroblast feature
from the Allen Brain Atlas, and (3) genes listed on the whole-
brain parvalbumin (PV) Neuroblast feature from the Allen Brain
Atlas. The Neuroblast feature of the Allen Brain Atlas identifies
genes with similar 3D spatial expression profiles by conducting
Pearson’s correlation coefficients of the expression intensity of
each gene with other genes coexpressed in 200μm cubes (Lein
et al., 2007). Although PGC-1α is not required for the expres-
sion of PV in the cerebellum as it is in the forebrain (Lucas et al.,
2010), the PVNeuroblast was implemented because of the signifi-
cant overlap between the neuroanatomical localization of PV and
PGC-1α in this brain region; transcript and protein expression of
both PGC-1α and PV is enriched Purkinje cells, molecular layer
interneurons, and neurons of the deep cerebellar nuclei (Celio,
1990; Cowell et al., 2007). Mined transcripts fitting our three
criteria but with unknown functions or ubiquitous expression
patterns when viewed on the Allen Brain Atlas were excluded
from subsequent analysis (Supplementary Table 2). The final list
consisted of 37 transcripts (Supplementary Table 3).
Expression levels of all 37 transcripts were measured, and
eight transcripts were found to be significantly reduced in cere-
bellar homogenates from PGC-1α−/− animals compared to
their littermate controls at 30 days of age (Figure 2). These
included the synaptic transcripts complexin 1 [Cplx1; F(2, 14) =
8.84, p = 0.005] and pacsin2 [F(2, 31) = 4.66, p = 0.02], the
structural transcript neurofilament heavy chain [Nefh; F(2, 15) =
11.87, p = 0.001], and the metabolism-related transcripts isoci-
trate dehydrogenase 3a [Idh3a; F(2, 15) = 8.75, p = 0.004], neu-
tral cholesterol ester hydrolase 1 [Nceh1; F(2, 31) = 6.42, p =
0.005], pyruvate dehydrogenase alpha 1 [Pdha1; F(2, 31) = 6.77,
p = 0.004], phytanoyl-CoA hydroxylase [Phyh; F(2, 31) = 11.46,
p = 0.0002], and ubiquinol-cytochrome c reductase, Rieske iron-
sulfur polypeptide 1 [Uqcrfs1; F(2, 31) = 4.47, p = 0.02]. Phyh
was the only gene to exhibit a dose-dependency with PGC-1α
expression, with significant differences between all genotypes,
while deletion of one allele was sufficient to cause decreases in
Cplx1, Idh3a, Pdha1, and Uqcrfs1 (Fisher’s LSD, p < 0.05).
NEUROANATOMICAL OVERLAP OF PGC-1A WITH NOVEL
PGC-1α-DEPENDENT GENES IN THE MOUSE CEREBELLUM
If Cplx1, Pacsin2, Nefh, Idh3a, Nceh1, Pdha1, Phyh, and Uqcrfs1
are truly PGC-1α-dependent genes, we surmised that they would
exhibit neuroanatomical overlap with PGC-1α in the cerebel-
lum. With the exception of Cplx1, Pacsin2, and Nefh, antibodies
against the protein products of PGC-1α-dependent transcripts
are either not commercially available or do not work well for
immunohistochemistry. Therefore, we collected in situ hybridiza-
tion images published on the Allen Brain Atlas (http://www.
brain-map.org) to determine the cellular localization of PGC-1α
and its putative targets in the adult mouse cerebellum (Figure 3).
At low magnification, PGC-1α mRNA exhibited high expression
in the Purkinje cell layer (PCL; arrowheads) and deep cerebellar
nuclei. Higher magnification of PGC-1α images in the cerebellar
cortex revealed high expression in the PCL, moderate expression
in the molecular layer (ML; arrows), and non-specific back-
ground expression in the granule cell layer (GCL), consistent with
published data on PGC-1α protein expression in this brain region
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FIGURE 1 | Ataxia characterized by altered gait kinematics in mice
lacking PGC-1α. CatWalk gait analysis was performed on male PGC-1α+/+
and −/− littermates at 6 months of age. PGC-1α−/− mice exhibited decreased
hindpaw area (A), increased hindpaw stand index (B), decreased forepaw
and hindpaw swing speed (C), and an increased number of missteps (D)
compared to their littermate controls. Representative digitized paw prints and
associated step cycles are shown in (E) with RF, right front paw, RH, right
hind paw, LF, left front paw, and LH, left hind paw. Two-tailed t-tests.
∗p < 0.05, ∗∗p < 0.005. n/group indicated on last bar histogram. Data are
presented as mean ± SEM.
FIGURE 2 | Novel cerebellar PGC-1α-dependent genes. q-RT-PCR of
microarray-identified PGC-1α regulated transcripts was performed on
cerebellar homogenates from PGC-1α+/+, +/−, and −/− littermates at
30 days of age. Expression of transcripts spanning synaptic (Cplx1,
Pacsin2; (A), structural [Nefh; (B)], and metabolic [Idh3a, Nceh1,
Pdha1, Phyh, Uqcrfs1; (C)] functions were significantly decreased in
PGC-1α−/− compared to littermate control cerebella. One-Way ANOVA
followed by Fisher’s LSD. ∗p < 0.05, ∗∗p < 0.005, ∗∗∗p < 0.0005.
n/group indicated on last bar histogram. Data are presented as
mean ± SEM.
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FIGURE 3 | Neuroanatomical mRNA localization of PGC-1α and its
dependent genes in the cerebellum. Sagittal in situ hybridization images of
PGC-1α (A), Cplx1 (B), Pacsin2 (C), Nefh (D), Idh3a (E), Nceh1 (F), Pdha1
(G), Phyh (H), and Uqcrfs1 (I) transcript expression in the adult mouse
cerebellum were collected from the Allen Brain Atlas (http://www.brain-map.
org). All transcripts are highly expressed in the Purkinje cell layer (PCL;
arrowheads) and the fastigial (FN) and interposed (IN) deep cerebellar nuclei.
Most transcripts also exhibited expression in the molecular layer (ML;
arrows), and Cplx1, Nefh, Phyh mRNA exhibited expression in the granule
cell layer (GCL; concave arrowheads). Boxed portion in A represents area of
higher magnification images in A′–I′. Scale bar = 525μm for A–I and 100μm
for A′–F′.
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(Cowell et al., 2007). All eight PGC-1α-dependent transcripts
exhibited high expression in the PCL and deep nuclei. Pascin2,
Idh3a, Nceh1, Pdha1, and Uqcrfs1 most closely resembled the
overall spatial pattern of PGC-1α, while Cplx1, Nefh, and Phyh
exhibited higher expression in the GCL (concave arrowheads).
REGION-SPECIFIC LOSS OF Cplx1 AND NEFH PROTEIN EXPRESSION IN
MICE LACKING PGC-1α
To investigate the likelihood of these changes in transcription
influencing cell function, we determined whether protein, as well
as transcript, expression of putative downstream targets of PGC-
1α was decreased in the cerebellum of PGC-1α−/− animals. To
initially quantify overall protein levels, we conducted Western
blot analysis on cerebellar homogenates from +/+ and −/−
animals at 1 month of age with commercially available anti-
bodies validated in our laboratory (Lucas et al., 2014). Of the
tested antibodies, only Cplx1, Nefh, and Pacsin2 produced spe-
cific bands at the correct molecular weight. Expression of Cplx1
[t(12) = 2.32, p = 0.02] and Nefh [t(12) = 2.16, p = 0.03], but
not Pacsin2, was significantly decreased in PGC-1α−/− compared
to +/+ littermates (Figure 4).
To localize the changes in protein expression to specific cell
types, we conducted immunofluorescence colabeling of Nefh
and Cplx with GAD67 in PGC-1α+/+ and −/− mice (Figure 5).
In +/+ animals, Nefh expression was highly concentrated in the
PCL with clear labeling in Purkinje cell bodies and their den-
dritic trees extending into the ML. However, in −/− animals,
Nefh labeling of Purkinje cells was greatly reduced, both in the
soma and the dendrites (Figure 5A). Contradictory to transcript
expression of Cplx1 (Figure 2B), labeling with an antibody that
recognizes both Cplx1 and Cplx2 did not reveal appreciable stain-
ing of Cplx in the PCL. In both +/+ and −/− animals, Cplx was
colocalized to GAD67-positive puncta surrounding Purkinje cell
bodies, and this expression did not appear to differ between +/+
and −/− mice (Figure 5B). In the deep cerebellar nuclei, how-
ever, there was a high intensity of Cplx staining that was greatly
reduced by deletion of PGC-1α (Figure 5C, interposed nucleus
shown). Cplx-positive cell bodies were not GAD67-positive in
this region, but Cplx exhibited a high degree of colocalization
with GAD67-positive processes, presumably from Purkinje cell
axon terminals. Cplx staining was greatly reduced in both the
GAD67-positive processes and GAD67-negative cell bodies of
deep cerebellar nuclei of −/− animals. Nefh expression, on the
other hand, did not appear to differ between +/+ and −/− mice
in the deep cerebellar nuclei (data not shown).
CONDITIONAL DELETION OF PGC-1α IN PV-POSITIVE CELLS DISRUPTS
TRANSCRIPTION OF CEREBELLAR PGC-1α-DEPENDENT GENES
Our immunofluorescence experiments suggest that the effects
of PGC-1α ablation appear to be specific to different cellular
populations, depending on the target transcript. However, the
differential effects of loss of PGC-1α in distinct cellular popula-
tions are consistent with the previously published protein (Cowell
et al., 2007) and mRNA (Figure 3) expression patterns demon-
strating high levels of PGC-1α in Purkinje cells, interneurons in
the ML, and cells of the deep cerebellar nuclei. Interestingly, all
of these populations express high levels of the calcium binding
protein parvalbumin (PV), so to test whether deletion of PGC-1α
specifically within these neuronal populations could recapitulate
the transcriptional deficiencies observed in the germline knock-
out animal, we crossed mice with LoxP sites flanking the 3–5 exon
region of the PGC-1α gene (Lin et al., 2004) with mice express-
ing Cre recombinase driven by the PV promoter (Hippenmeyer
et al., 2005). Cell-specific recombination was confirmed using
reporter mice that express red fluorescent protein in the absence
of recombination and green fluorescent protein (GFP) in the pres-
ence of recombination (Muzumdar et al., 2007). At 3 months
of age, reporter mice exhibited GFP expression in the PCL and
ML but not the GCL of the cerebellar cortex and in the deep
cerebellar nuclei (Figures 6A,B), with the highest GFP expres-
sion in Purkinje cell bodies and axon terminals in the deep
nuclei.
FIGURE 4 | Decreased protein expression of Nefh and Cplx1 in mice
lacking PGC-1α. Western blot analysis was performed on cerebellar
homogenates of PGC-1α+/+ and −/− littermates at 30 days of age to
determine if protein of PGC-1α-dependent genes was downregulated in a
similar manner as the transcript. Expression of Cplx1 and Nefh, but not
Pacsin2, was significantly reduced in −/− compared to +/+ animals (A).
Representative Western blots are shown in (B). One-tailed t-tests. ∗p < 0.05.
n = 7/group. Data are presented as mean ± SEM.
Frontiers in Cellular Neuroscience www.frontiersin.org January 2015 | Volume 8 | Article 441 | 7
Lucas et al. PGC-1α and Purkinje cell vulnerability
FIGURE 5 | Localization of Nefh and Cplx in PGC-1α −/− mice. Confocal
microscopy photos of immunofluorescence double-labeling of GAD67 with
Nefh and Cplx1,2 reveals a differential reduction in the expression of these
proteins in PGC-1α−/− cerebellum. (A) Nefh exhibited high expression in
Purkinje cell bodies (arrowheads) and dendritic processes in +/+ mice.
Somatic and dendritic expression was greatly reduced in the Purkinje cells
of −/− animals. (B) Immunoreactivity for an antibody that recognizes both
Cplx1 and Cplx2 did not reveal great expression for these proteins in
Purkinje cell bodies (arrowheads), although some colocalization with
GAD67-positive puncta surrounding Purkinje cells was observed in both +/+
and −/− mice. (C) Cplx expression was of the greatest intensity in the deep
cerebellar nuclei (interposed nucleus shown) in +/+ animals. Cplx-positive
cell bodies (arrowheads) were not GAD67-positive in the region, but Cplx
exhibited a high degree of colocalization with GAD67-positive processes
(note the high degree of GAD67 innervation of Cplx-positive cell bodies,
presumably from Purkinje cell axon terminals). Cplx staining was greatly
reduced in deep cerebellar nuclei of −/− animals. n = 4−5/group. Scale
bars = 50μm.
FIGURE 6 | Conditional deletion of PGC-1α in PV-positive cells
decreases transcript expression of novel cerebellar PGC-1α-dependent
genes. To conditionally delete PGC-1α in a manner consistent with its
reported expression (i.e., Purkinje cells, inhibitory interneurons of the
cerebellar cortex, and cells of the deep cerebellar nuclei) PGC-1α floxed
mice were crossed with mice expressing Cre recombinase driven by the
parvalbumin promoter (PV-Cre). PV-Cre mice were crossed with mutant
tomato/mutant green reporter mice to determine the specificity of
Cre-mediated recombination at 3 months of age. PV expression is
pseudocolored red from Cy5. (A) Green fluorescent protein (GFP)
expression was high in the Purkinje cell layer (PCL; arrowheads), moderate
in the molecular layer (ML), and low in the granule cell layer (GCL). Scale
bar = 25μm. (B) GFP expression was greatest in the deep cerebellar nuclei
(interposed nucleus shown) and exhibited a high degree of colocalization to
PV-positive terminals and, to a lesser extent, PV-positive cell bodies
(arrowheads). Note the absence of GFP expression outside the borders of
the nucleus (arrows). Scale bar = 75μm. (C) Gene expression of PGC-1α
and its putative targets was measured in cerebellar homogenates from
6-month-old PGC-1αWT and fl/fl mice expressing PV-Cre by q-RT-PCR.
Expression of PGC-1α, Cplx1, Nefh, Idh3a, and Uqcrfs1 were significantly
reduced in PGC-1αfl/fl:PV-Cre mice. One-tailed t-tests. ∗∗∗p < 0.0005,
∗p < 0.05. n/group indicated on last bar histogram. Data presented as mean
± SEM.
Gene expression was measured by q-RT-PCR in cerebellar
homogenates from PGC-1αWT:PV-Cre and PGC-1αfl/fl:PV-Cre
littermates at 6 months of age (Figure 6C). Conditional deletion
of PGC-1α by PV-Cre resulted in a 50% decrease in the expression
of PGC-1α [t(23) = 7.69, p = 4.21 × 10−8] and also significantly
reduced expression of Cplx1 [t(23) = 8.57, p = 6.52 × 10−9],
Nefh [t(23) = 5.29, p = 1.34 × 10−5], Idh3a [t(23) = 7.48, p =
6.68 × 10−8; Figure 6C], and Uqcrfs1 [t(20) = 1.83, p = 0.04].
Interestingly, Pacsin2, Nceh1, Pdha1, and Phyh gene expression
was unaffected by conditional deletion of PGC-1α, despite their
apparent concentration in Purkinje cells (Figure 2). It is possible
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that Pacsin2, Nceh1, Pdha1, and Phyh are dependent on PGC-
1α in PV-negative cell types or that cell-cell interactions in the
complete knockout are required for decreases in their expression.
PGC-1α ABLATION DECREASES PURKINJE CELL VIABILITY AND
FUNCTION
Purkinje cells exhibit a particularly high concentration of PGC-1α
(Cowell et al., 2007), and our immunofluorescence and con-
ditional knockout experiments suggest that Purkinje cells are
dependent on PGC-1α for transcriptional regulation. Thus, we
questioned whether the combined decrease of synaptic, struc-
tural, and metabolism-related genes caused by ablation of PGC-
1α would lead to decreased neuronal viability and/or function
in this cellular population. As a measure of Purkinje cell viabil-
ity, we conducted stereological counts of H&E stained Purkinje
cells in PGC-1α+/+ and −/− mice at 6 weeks of age, a time point
after the onset of the previously described neurodegeneration in
the striatum of this mouse line (Lucas et al., 2012). H&E labeling
of Purkinje cells in PGC-1α+/+ animals exhibited a clear nuclear
haematoxylin stain, while the haematoxylin stain of Purkinje cells
in −/− mice was often very faint and cell bodies were at times
undetectable between theML and GCL (Figure 7A). Stereological
estimation with the optical fractionator method demonstrated
a ∼30% reduction of the total number of Purkinje cells in −/−
compared to +/+ animals [t(8) = 3.83, p = 0.005; Figure 7B].
Purkinje cells are one of the few neuronal populations that are
spontaneously active in the absence of synaptic input (Hausser
and Clark, 1997), allowing their firing rates to be measured in
the absence of stimulation or drug application. As a measure
of Purkinje cell basal function, we performed loose patch elec-
trophysiology on Purkinje cells in vitro in acute cerebellar slices
from PGC-1α+/+ and −/− animals at 6 weeks of age. Slices
were perfused with oxygenated ACSF; once patched, Purkinje
cells were allowed to acclimate to the pipette for 3min to avoid
events in response tomechanical stimulation. Spontaneous events
were then recorded for 3min with no stimulation (Figure 7C).
We observed a 50% reduction in Purkinje cell spike rate in
PGC-1α−/− compared to +/+ animals [t(5) = 3.09, p = 0.03;
Figure 7D].
DISCUSSION
In this manuscript, we present data showing that mice lacking
PGC-1α exhibit a behavioral phenotype indicative of cerebellar
dysfunction and show reduced cerebellar expression of tran-
scripts involved in synaptic (Cplx1, Pacsin2), structural (Nefh),
and metabolic (Idh3a, Nceh1, Pdha1, Phyh, and Uqcrfs1) func-
tions. Using mice expressing Cre recombinase under the control
of the PV promoter, we postnatally ablated PGC-1α in neu-
ronal types enriched in its expression and observed reduced
transcript expression of PGC-1α and its dependent genes Cplx1,
Nefh, Idh3a, and Uqcrsf1, suggesting that PGC-1α regulation
of these transcripts is specific to Purkinje cells, interneurons of
the cerebellar cortex, and neurons of the deep cerebellar nuclei
(Supplementary Table 4). Recombination in our conditional
FIGURE 7 | PGC-1α ablation results in decreased Purkinje cell viability
and function by 6 weeks of life. (A) Stereological counts of Purkinje cells
stained with hematoxylin and eosin (H&E) were conducted to obtain an
unbiased estimate of the number of Purkinje cells. At 6 weeks of age,
PGC-1α−/− had significantly fewer Purkinje cells than +/+ littermates.
(B) Representative pictures of H&E stained Purkinje cells from 6-week-old
animals. Note the deep staining in +/+ animals compared to the often
undetectable stain in the Purkinje cell layer (PCL) of −/− animals. GCL,
granule cell layer. ML, molecular layer. Scale bar = 100μm. (C) Loose patch
electrophysiology was conducted in acute cerebellar slices to determine if
loss of PGC-1α leads to Purkinje cell dysfunction. (D) Purkinje cell spike rate
was significantly reduced in PGC-1α−/− compared to +/+ mice.
Representative traces shown in (C) Two-tailed t-tests. ∗∗p < 0.005,
∗p < 0.05. n/group indicated on bar histograms. For electrophysiology data,
the number of animals is indicated in parentheses after the number of cells.
Data presented as mean ± SEM.
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knockout animals was highest in Purkinje cells, and germline
deletion of PGC-1α resulted in Purkinje cell loss and physiological
dysfunction.
As the novel cerebellar PGC-1α-dependent transcripts are
both upregulated by PGC-1α overexpression (in vitro data from
Lucas et al., 2014) and reduced by its deletion (in vivo data
from Figure 2), we hypothesize that Cplx1, Pacsin2, Nefh, Idh3a,
Nceh1, Pdha1, Phyh, and Uqcrfs1 are all directly regulated by
PGC-1α. To definitively determine whether these transcripts are
direct targets of PGC-1α, chromatin immunoprecipitation assays
are required; however, considering the cell type-specific differ-
ences in vulnerability to PGC-1α loss, these experiments are
impractical. An alternative approach would be to identify the
common intermediate transcription factors that PGC-1α inter-
acts with to drive their expression. It is possible that genes within
certain functional categories (neurotransmitter release, axonal
structural support, and metabolism) are driven by PGC-1α’s
interaction with distinct sets of transcriptional regulators; for
example, transcription of metabolic genes may be driven by the
PGC-1α-interacting factor nuclear respiratory factor 1 (Wu et al.,
1999). Further elucidation of the PGC-1α interactomemay clarify
the mechanisms by which PGC-1α can regulate parallel programs
for functional, structural, and metabolic maturation.
Cplx1 and Nefh, but not Pascin2, were also decreased at the
protein level in the cerebellum of PGC-1α−/− mice. When we
investigated the cellular distribution of protein expression, we
found that Nefh was decreased in Purkinje cell bodies and den-
dritic processes, while Cplx was decreased in the deep cerebellar
nuclei. Contradictory to the transcript pattern of Cplx1, very lit-
tle Cplx protein was observed in the PCL. It is possible that the
reduction in Cplx protein expression that was observed in the
deep cerebellar nuclei was due to a loss of this synaptic protein in
the axonal projections of Purkinje cells, whose sole synaptic tar-
gets are the deep cerebellar nuclei. However, we did not observe
changes in Nefh expression in the white matter tracts from the
Purkinje cells to the deep cerebellar nuclei, suggesting that the
Purkinje cell axons themselves are still present. At the synapse,
Cplx1 mediates synchronous neurotransmitter release by clamp-
ing the vesicle to the presynaptic membrane in a primed but
unfused manner, thus controlling the timing of vesicular exocy-
tosis (Sudhof and Rothman, 2009). Future experiments should
be conducted to determine whether neurotransmitter release
from Purkinje cells to the deep cerebellar nuclei is asynchronous,
as abnormalities in synchronous neurotransmitter release were
observed in the motor cortex of PGC-1αfl/fl:PV-Cre mice (Lucas
et al., 2014).
While it has been established that loss of PGC-1α leads to vac-
uolization in motor regions of the forebrain (Lin et al., 2004;
Leone et al., 2005; Lucas et al., 2012), no investigations of PGC-
1α loss on cell viability have been conducted in the cerebellum to
date. We here show a ∼30% reduction in Purkinje cell number
in PGC-1α−/− mice, indicating that Purkinje cells are vulnerable
to cell death in the absence of PGC-1α. Of the novel PGC-
1α-dependent genes identified in this manuscript, Phyh is the
only gene that has been shown to influence Purkinje cell viabil-
ity. Mutations in the Phyh gene result in an autosomal recessive
lipid storage disorder known as Refsum disease (Jansen et al.,
1997). Clinically, patients present with severe cerebellar ataxia
(Wierzbicki, 2007), and loss of Purkinje cells accompanied by
ataxia has been reported in a Phyh −/− mouse model of this
disease (Ferdinandusse et al., 2008).
While decreased Phyh expression is the most direct link
between loss of PGC-1α and reduced Purkinje cell viability,
it is also possible that compromised metabolism contributes
to the observed cell loss. We previously found that the mito-
chondrial fusion gene mitofusin 2 (Mfn2) and the antioxidant
gene manganese superoxide dismutase (MnSOD), both well-
established targets of PGC-1α, were significantly reduced in cere-
bellar homogenates from PGC-1α−/− mice (Lucas et al., 2010).
Here, we reported that Uqcrfs1 is also a cerebellar PGC-1α-
dependent gene. Uqcrfs1 is a component of complex III of the
mitochondrial electron transport chain, and while other mem-
bers of complex III can associate to form a complex in the
absence of uqcrfs1, the resultant complex has limited enzymatic
activity, leading to the degradation of complexes I and IV (Diaz
et al., 2012). Thus, the combined decreases in expression of
the metabolism-related genes Phyh, Idh3a, Mfn2, MnSOD, and
Uqcrfs1 may lead to abnormalities in energy homeostasis or
the increased production of reactive oxygen species, contribut-
ing to decreased viability of Purkinje cells of PGC-1α−/− animals.
Reduced energy production could also explain the decrease in
spike rate, as none of the other PGC-1α-dependent genes iden-
tified to date, alone or in combination, have been reported to
produce this physiological abnormality. Of note, cortical PV-
positive interneurons also exhibit a decrease in firing rate in
PGC-1α−/− mice (Dougherty et al., 2014).
We previously reported that, in contrast to the cerebrum, PV
expression in the cerebellum is not dependent on the presence
of PGC-1α (Lucas et al., 2010). Here, no changes in the expres-
sion of synaptotagmin 2 (Syt2) were observed in the cerebellum of
PGC-1α−/− mice (Supplementary Table 3), while Syt2 is reduced
by∼80% in the cortex of these mice (Lucas et al., 2014). This sug-
gests that the mechanisms of PGC-1α-mediated gene regulation
differ by region and cell type in the brain. Since PGC-1α’s gene
targets are defined by the transcription factors with which it inter-
acts, it is likely that a different complement of factors interact with
PGC-1α in cortical neurons than in cerebellar neurons. Multiple
PGC-1α-interacting factors such as CREB, myocyte enhancing
factor 2, and thyroid hormone receptor are expressed highly in the
cerebellum; identification of the predominant factors that interact
with PGC-1α in individual cell types would assist in predicting the
specific subset of transcripts that would be affected by PGC-1α
deficiency.
Regarding our observation of ataxia in PGC-1α−/− mice, it
is not currently clear which cell populations are contributing to
this phenotype. A recent publication suggests that gait abnor-
malities in PGC-1α−/− mice are more consistent with Purkinje
cell dysfunction than dysfunction of granule cells or molecu-
lar layer interneurons (Vinueza Veloz et al., 2014). However, we
did not perform CatWalk analysis on PGC-1αfl/fl:PV-Cre mice
because our previous study did not reveal deficits in locomo-
tor activity or motor coordination in these animals (Lucas et al.,
2014). It is possible that the ataxia phenotype arises from cells
that do not express PV, such as granule cells. As granule cell
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loss has been reported in Cplx1 −/− mice (Kielar et al., 2012),
which exhibit profound ataxia (Glynn et al., 2005), PGC-1α may
play an important role in regulation of Cplx1 and other depen-
dent genes in granule cells. Other cells that could contribute to
the ataxia phenotype could be motor neurons; it has not been
shown whether motor neurons express PGC-1α, although over-
expression of PGC-1α is capable of slowing disease progression
in a mouse model of amyotrophic lateral sclerosis (Liang et al.,
2011). A preliminary analysis of PGC-1α mRNA localization in
the spinal cord using Allen Brain Atlas shows that PGC-1αmRNA
is present in a subset of large neurons in the ventral gray matter of
the spinal cord; gene expression loss, especially of Nefh which is
highly concentrated in those cells, could be contributing to some
of the motor deficits. Muscle cells are also affected by a lack of
PGC-1α, although mice with muscle-specific deletion show only
subtle motor impairments (Handschin et al., 2007).
It is also important to consider age differences when inter-
preting our behavioral data (conducted at 6 months of age) in
light of our molecular findings (conducted at 4–6 weeks of age).
Due to significantly decreased weight in PGC-1α−/− mice at
younger ages, gait analysis was conducted on mice at 6 months
of age, when weight does not differ from PGC-1α+/+ mice, as
differences in weight between genotypes can bias paw print detec-
tion with the automated Catwalk program. While we previously
observed that striatal vacuolization and impaired rotarod per-
formance does not significantly improve or decline between 1
and 3 months of age (Lucas et al., 2012), it is possible, given
the additional metabolic targets in the cerebellum compared to
the forebrain, that gait abnormalities are more pronounced at 6
months than earlier ages. While we did not perform transcrip-
tional analysis from cerebella of 6 month-old PGC-1a −/− mice,
we would predict that the putative targets that are reduced at 30
days of age would still be reduced at later ages (as demonstrated
for the striatum; Lucas et al., 2012), but that other “off-target”
transcripts may also be affected, due to compensatory mecha-
nisms. Future studies will evaluate balance and gait in a cohort
of younger animals with semi-quantitative approaches (Guyenet
et al., 2010).
Recently, PGC-1α was also found to be involved in the pathol-
ogy of Friedreich Ataxia. Friedreich Ataxia is an autosomal
recessive disorder and is the most common of the early-onset
hereditary ataxias (Pandolfo, 2009). Friedreich Ataxia is caused by
an expanded GAA triplet repeat in the first intron of the frataxin
gene, resulting in a 65–95% reduction in frataxin expression in
Friedreich Ataxia patients (Campuzano et al., 1996). Transcript
expression of PGC-1α and its downstream target MnSOD was
found to be decreased in fibroblasts and lymphoblasts of patients
with Friedreich Ataxia (Coppola et al., 2009; Marmolino et al.,
2010). In fact, transcript expression of frataxin is highly correlated
with that of PGC-1α in Friedreich Ataxia and control cells, and
knock down of frataxin in cell culture also decreases transcript
expression of PGC-1α (Coppola et al., 2009).
Related to the potential roles for PGC-1α in cerebellar gene
dysregulation in other movement disorders, we have recently
observed that the firing rate of Purkinje cells is reduced in
transgenic and knock-in mouse models of Huntington Disease
(Dougherty et al., 2012, 2013). Due to the interconnectivity
between the basal ganglia and cerebellum and their joint roles in
motor coordination and gait control, it is possible that cerebellar
deficits contribute to the motor symptoms in Parkinson Disease
as well (Wu and Hallett, 2013). Of note, the kinematic ataxia phe-
notype observed in PGC-1α−/− mice (Figure 1) closely resem-
bles the gait abnormalities reported in rodent models of both
Huntington (Vandeputte et al., 2010) and Parkinson (Vlamings
et al., 2007; Chuang et al., 2010) Diseases. Further experiments
are required to determine whether dysregulation of PGC-1α-
dependent programs of gene expression underlies some of the
cell- and circuit-specific vulnerability in these disorders.
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